The MCL-1 targeting effect of alvocidib potentiates the activity of cytarabine and mitoxantrone in a time-sequential regimen in AML
Autor: | Kim, Wontak, Bahr, Brigham L., Soh, Katherine K., Bearss, Jeremiah J., Sol Lee, Ye, Peterson, Peter, Whatcott, Clifford J., Siddiqui-Jain, Adam, Weitman, Steven, Bearss, David J., Warner, Steven L. |
---|---|
Zdroj: | In Clinical Lymphoma Myeloma and Leukemia September 2015 15 Supplement 2:S18-S18 |
Databáze: | ScienceDirect |
Externí odkaz: |